Sema Yılmaz
- Rheumatology top 5%
- Cardiology and Cardiovascular Medicine
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Immunology
- Co-authors
- Hakan GüllüHaldun MüderrisoğluEftal YücelDoğan ErdoğanMustafa ÇalışkanAylin Yı́ldı́rı́rÖzgür ÇiftçiSeyra Erbek
- Topics
- Rheumatoid Arthritis Research and Therapies (9 papers)Systemic Lupus Erythematosus Research (8 papers)Spondyloarthritis Studies and Treatments (7 papers)
- Journals
- SHILAP Revista de lepidopterologíaScientific ReportsAnnals of the Rheumatic Diseases
- Partner nations
- TürkiyeUnited StatesRussia
In The Last Decade
Sema Yılmaz
47 papers receiving 463 citations
Peers
Comparison fields: 5 of 82
- Rheumatology 193
- Cardiology and Cardiovascular Medicine 97
- Pulmonary and Respiratory Medicine 89
- Molecular Biology 81
- Immunology 60
Countries citing papers authored by Sema Yılmaz
This map shows the geographic impact of Sema Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sema Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sema Yılmaz more than expected).
Fields of papers citing papers by Sema Yılmaz
This network shows the impact of papers produced by Sema Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sema Yılmaz. The network helps show where Sema Yılmaz may publish in the future.
Co-authorship network of co-authors of Sema Yılmaz
This figure shows the co-authorship network connecting the top 25 collaborators of Sema Yılmaz. A scholar is included among the top collaborators of Sema Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sema Yılmaz. Sema Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 0 | |
| 9 | 19 | |
| 10 | 8 | |
| 11 | 13 | |
| 12 | 12 | |
| 13 | Meropenem monotherapy as an empirical treatment of febrile neutropenia in childhood cancer patients. | 6 |
| 14 | 7 | |
| 15 | 5 | |
| 16 | 74 | |
| 17 | 9 | |
| 18 | 17 | |
| 19 | 89 | |
| 20 | 16 |
About Sema Yılmaz
Sema Yılmaz is a scholar working on Rheumatology, Ophthalmology and Transplantation, having authored 50 papers that have together received 473 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (9 papers), Systemic Lupus Erythematosus Research (8 papers) and Spondyloarthritis Studies and Treatments (7 papers). The work is most often cited by research in Rheumatology (193 citations), Ophthalmology (58 citations) and Sensory Systems (23 citations). Sema Yılmaz has collaborated with scholars based in Türkiye, United States and Russia. Frequent co-authors include Hakan Güllü, Haldun Müderrisoğlu, Eftal Yücel, Doğan Erdoğan, Mustafa Çalışkan, Aylin Yı́ldı́rı́r, Özgür Çiftçi, Seyra Erbek, Selim S. Erbek and Semra Topçu. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.